Influence of plasma exchange on rituximab pharmacokinetics

British Journal of Clinical Pharmacology

Volumn 76, Issue 3, 2013, Pages 486-488

  Azzopardi, Nicolas ^a,b   François, Maud ^c   Laurent, Émeline ^c   Paintaud, Gilles ^a,b,c   Birmelé, Béatrice ^c  

^a CNRS   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c UNIVERSITY HOSPITAL OF TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; RITUXIMAB;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BONE MARROW TRANSPLANTATION; CANCER PATIENT; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG EXPOSURE; DRUG INFUSION; DRUG MONITORING; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HUMAN; LIVER TRANSPLANTATION; MALE; MARGINAL ZONE LYMPHOMA; MAXIMUM PLASMA CONCENTRATION; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MOLECULAR WEIGHT; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; PLASMAPHERESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT DURATION;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; COMPUTER SIMULATION; CRYOGLOBULINEMIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PLASMA EXCHANGE;

EID: 84882701226     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12167     Document Type: Article

References (6)

1. Gorman C, Leandro M, Isenberg D. B cell depletion in autoimmune disease. Arthritis Res Ther 2003; 5: S17-21.
2. Patriarca F, Medeot M, Isola M, Battista ML, Sperotto A, Pipan C, Toffoletti E, Dozzo M, Michelutti A, Gregoraci G, Geromin A, Cerno M, Savignano C, Rinaldi C, Barbone F, Fanin R. Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab. Transpl Infect Dis 2013; 15: 259-267.
3. Faguer S, Kamar N, Guilbeaud-Frugier C, Fort M, Modesto A, Mari A, Ribes D, Cointault O, Lavayssière L, Guitard J, Durand D, Rostaing L. Rituximab therapy for acute humoral rejection after kidney transplantation. Transplantation 2007; 83: 1277-1280.
4. Nojima M, Yoshimoto T, Nakao A, Itahana R, Kyo M, Hashimoto M, Shima H. Sequential blood level monitoring of basiliximab during multisession plasmapheresis in a kidney transplant recipient. Transplant Proc 2005; 37: 875-878.
5. McDonald V, Manns K, Mackie IJ, Machin SJ, Scully MA. Rituximab pharmacokinetics during the management of acute idiopathic thrombotic thrombocytopenic purpura. J Thromb Haemost 2010; 8: 1201-1208.
6. Blasco H, Lalmanach G, Godat E, Maurel MC, Canepa S, Belghazi M, Paintaud G, Degenne D, Chatelut E, Cartron G, Le Guellec C. Evaluation of a peptide ELISA for the detection of rituximab in serum. J Immunol Methods 2007; 325: 127-139.